Nemoto, Yuki
Ishihara, Hiroki http://orcid.org/0000-0002-5146-656X
Nakamura, Kazutaka
Tachibana, Hidekazu
Fukuda, Hironori
Yoshida, Kazuhiko
Kobayashi, Hirohito
Iizuka, Junpei
Shimmura, Hiroaki
Hashimoto, Yasunobu
Tanabe, Kazunari
Kondo, Tsunenori
Takagi, Toshio
Article History
Accepted: 1 June 2022
First Online: 5 July 2022
Declarations
:
: No external funding was used in the preparation of this article.
: Toshio Takagi received honoraria from Bristol-Myers Squibb and Ono Pharmaceutical. Tsunenori Kondo received honoraria from Pfizer, Novartis, Bristol-Myers Squibb, and Ono Pharmaceutical. Yuki Nemoto, Hiroki Ishihara, Kazutaka Nakamura, Hidekazu Tachibana, Hironori Fukuda, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Hiroaki Shimmura, Yasunobu Hashimoto, and Kazunari Tanabe have no conflicts of interest relevant to the contents of this article.
: The study protocol was approved by the Institutional Ethics Review Board of each institution (Tokyo Women’s Medical University, Tokyo Women’s Medical University Adachi Medical Center, Saiseikai Kawaguchi General Hospital, Saiseikai Kurihashi Hospital, and Jyoban Hospital; ID: 2020-0009). The present study was performed according to the guidelines of the 1964 Declaration of Helsinki and its later amendments. Owing to the retrospective observational nature of this study, the need for informed consent was waived.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to this study’s conception and design, data collection, and analysis. The first draft of the manuscript was written by Yuki Nemoto and all authors commented on the previous drafts of the manuscript. All authors read and approved the final version of the manuscript.